Runner Up: Terbinafine-Resistant Dermatophytosis in Alabama: Two Cases of Recalcitrant Dermatophytosis and the Dermatologist’s Role in Detection of Drug Resistance and Antifungal Stewardship
Main Article Content
Keywords
infection
Abstract
Abstract not available.
References
Single A, Gupta S, Vasani R, Saraswat A, Madhu R, Panda S, Das A, Kura MM, Kumar A, Poojary S, Schirm S, Gräser Y,
Paasch U, Nenoff P. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre
study. Mycoses. 2020 Jul;63(7):717-728. doi: 10.1111/myc.13091. Epub 2020 May 4. PMID: 32301159.Saunte, Ditte
M. .., et al. “Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene
Mutations, and a Reliable EUCAST Method for Detection.” Antimicrobial Agents and Chemotherapy, vol. 63, no. 10,
American Society for Microbiology, 2019, https://doi.org/10.1128/AAC.01126-19.
2. Taghipour S, Shamsizadeh F, Pchelin IM, Rezaei-Matehhkolaei A, Zarei Mahmoudabadi A, Valadan R, Ansari S,
Katiraee F, Pakshir K, Zomorodian K, Abastabar M. Emergence of Terbinafine Resistant Trichophyton
mentagrophytes in Iran, Harboring Mutations in the Squalene Epoxidase (SQLE) Gene. Infect Drug Resist. 2020 Mar
13;13:845-850. doi: 10.2147/IDR.S246025. PMID: 32214830; PMCID: PMC7078656.
3. Barros, Maria Elisabete da Silva, et al. “Evaluation of Susceptibility of Trichophyton Mentagrophytes and
Trichophyton Rubrum Clinical Isolates to Antifungal Drugs Using a Modified CLSI Microdilution Method (M38-A).”
Journal of Medical Microbiology, vol. 56, no. 4, Soc General Microbiol, 2007, pp. 514–18,
https://doi.org/10.1099/jmm.0.46542-0.
4. Clinical and Laboratory Standards Institute (2002). Reference Method for Broth Dilution Antifungal Susceptibility
Testing of Filamentous Fungi, approved standard M38-A. Wayne, PA: Clinical and Laboratory Standards Institute
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.